Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.91 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.34 |
| ▸ | MAPK13 | O15264 | 4/20 | 0.34 |
| ▸ | MAPK12 | P53778 | 4/20 | 0.34 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.34 |
| ▸ | GCGR | P47871 | 3/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | SELP | P16109 | 2/20 | 0.33 |
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | BRAF | P15056 | 1/20 | 0.32 |
| ▸ | RAF1 | P04049 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13679717 | 1.00 | ABCB1 (0.91) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL3826448 | 0.95 | ABCB1 (1.00) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL719050 | 0.95 | ABCB1 (1.00) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL30357745 | 0.93 | ABCB1 (0.87) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL13679699 | 0.91 | ABCB1 (0.92) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL3830858 | 0.91 | ABCB1 (0.92) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL3824437 | 0.91 | ABCB1 (0.91) | ABCB1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL13780563 | 0.91 | ABCB1 (0.91) | ABCB1PTPN1MAPTNOX1MAPK13 | |
| SCHEMBL13679665 | 0.91 | ABCB1 (0.91) | ABCB1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL5468480 | 0.90 | ABCB1 (0.89) | ABCB1PTPN1MAPTNOX1MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0999835-B1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | TAIJI BIOMEDICAL INC (US) | 2009-09-09 | — | — | EP | disclosed |
| EP-2082740-A2 | Use of imidazole derivatives as MDR modulators | Taiji Biomedical, Inc. (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-0999835-A4 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORP (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-0999835-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | Ontogen Corporation (US) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999002155-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORPORATION (US) | 1999-01-21 | — | — | WO | disclosed |
| US-5840721-A | INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS | ONTOGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |